Dietary Fructans, but Not Cellulose, Decrease Triglyceride Accumulation in the Liver of Obese Zucker fa/fa Rats-Reference-Cited by-同舟云学术

Dietary Fructans, but Not Cellulose, Decrease Triglyceride Accumulation in the Liver of Obese Zucker fa/fa Rats

Published:2002-05-01 Issue:5 Volume:132 Page:967-973
ISSN:0022-3166
Container-title:The Journal of Nutrition
language:en
Short-container-title:

Author:

Daubioul Catherine¹,Rousseau Nicolas¹,Demeure Roger²,Gallez Bernard²³,Taper Henryk¹,Declerck Barbara¹,Delzenne Nathalie¹

Affiliation:

1. Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology 7369 School of Pharmacy, Université catholique de Louvain, B-1200 Brussels, Belgium;

2. Laboratory of Biomedical Magnetic Resonance and

3. Laboratory of Medicinal Chemistry and Radiopharmacy, UCL, Brussels, Belgium

Publisher

Oxford University Press (OUP)

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://academic.oup.com/jn/article-pdf/132/5/967/24017171/4w0502000967.pdf

Reference51 articles.

1. Non-alcoholic steatohepatitis: another disease of affluence;James;The Lancet,1999

2. Effects of short-term leptin exposure on triglyceride deposition in rat liver;Roden;Hepatology,2000

3. Etiopathogenesis of non alcoholic steatohepatitis;Chitturi;Semin. Liver Dis.,2001

4. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance;James;J. Hepatol.,1998

5. Rosiglitazone reduces liver lipid in Zucker rat: a 1H MRS study;Hockings;Proc. Int. Soc. Magn. Reson. Med.,2001

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibacterial and antibiofilm potentials of vancomycin-loaded niosomal drug delivery system against methicillin-resistant Staphylococcus aureus (MRSA) infections;BMC Biotechnology;2024-07-08

2. Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis;Biomedicines;2024-02-29

3. Bio-functional activities of agavins on health;Studies in Natural Products Chemistry;2024

4. Niosomal-Based Drug Delivery Platforms: A Promising Therapeutic Approach to Fight Staphylococcus aureus Drug Resistance;Journal of Nanomaterials;2023-12-07

5. Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies;Gut Microbes;2023-06-26